Nitrome Biosciences

As a platform company developing drugs against a newly identified class of enzymes, Nitrome Biosciences will have found and characterized this class of enzymes and will have paved a novel inroad into the proprietary development of disease-modifying therapies. They are initially targeting Parkinson’s... Read more